Dear Doctors: I heard there will be a saliva test to see who has a high risk of getting prostate cancer. I don’t see how saliva would have anything to do with your prostate gland. How does the test ...

Dear Doctors: I heard there will be a saliva test to see who has a high risk of getting prostate cancer. I don't see how saliva would have anything to do with your prostate gland. How does the test ...

In the month of October, many organizations use the color pink to raise awareness for breast cancer. Women are encouraged to do regular home exams and to attend their annual mammograms. For men, ...

A new at-home spit test for prostate cancer may be better than current blood tests, a new study shows. The simple saliva test has been developed by experts and works by analysing genetic variants in a ...

Dear Doctors: I heard there will be a saliva test to see who has a high risk of getting prostate cancer. I don't see how saliva would have anything to do with your prostate gland. How does the test ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer is ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

The ArteraAI Prostate Test uses AI to analyze biopsy images, predicting hormone therapy benefits for prostate cancer patients. Approved in the US and UK, the test aids early diagnostic decisions, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...

A prostate cancer charity has voiced concerns regarding the planned introduction of at-home prostate-specific antigen (PSA) tests, urging for greater clarity on how men with the disease will utilise ...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic ...